The perils of cheap fertility drugs
By Professor Bill Ledger,
BBC News
| 04. 21. 2010
[Commentary]
VIEWPOINT
Professor Bill Ledger, Professor of Obstetrics & Gynaecology, Sheffield University
During the 90s multiple births rose as doctors implanted a number of embryos into women having IVF - this has since been reduced.
But the multiple birth rate is still on the increase.
In this week's Scrubbing Up, leading fertility expert Professor Bill Ledger says part of the problem is the liberal use of cheap fertility drugs, and warns there will be dire consequences if this does not end.
There can be no doubt that having one child at a time is best for both mother and baby.
Multiple births often happen too early, with risk of neonatal illness needing intensive care, and sometimes permanent disability as a result.
Rates of twin and triplet birth were too high in the UK the 1990s because well-meaning fertility specialists were transferring too many embryos after IVF.
" These drugs need tighter control because whilst the high tech end of fertility medicine is highly regulated in UK, any doctor can prescribe these drugs "
The Human Fertilisation and Embryology Authority (HFEA) has...
Related Articles
By Paula Siverino Bavio, BioNews | 03.16.2026
State flag of Peru via Wikimedia Commons licensed under CC by SA 2.0
A recent surrogacy case in Peru had a good outcome for one family, but does not provide wider certainty for families, surrogates or clinicians, writes Dr Paula...
By Antonia O'Flaherty, ABC News Australia | 03.04.2026
Fertility giant Monash IVF has agreed to pay financial settlements to families involved in two major bungles that saw two women transferred the wrong embryo.
In February 2025 the company became aware that one of its Brisbane clinic's patients had...
By Dr. Marcin Śmietana, Progress Educational Trust (PET) | 03.02.2026
When a family created through surrogacy abroad returns to their home country after the birth of the child, the genetic parent(s) are usually recognised as legal parents by default. However, any parent without a genetic link to the child needs...
By Tania Fabo, Truthout | 02.28.2026
The reproductive tech company Orchid recently launched a genetic test that promises a whole genome sequencing report for embryos. It is the first such test commercially available to couples undergoing in vitro fertilization (IVF) and claims to detect things like...